vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）とEcovyst Inc.（ECVT）の財務データ比較。上の社名をクリックして会社を切り替えられます
COLLEGIUM PHARMACEUTICAL, INCの直近四半期売上が大きい（$205.4M vs $199.4M、Ecovyst Inc.の約1.0倍）。Ecovyst Inc.の前年同期比売上増加率が高い（34.0% vs 12.9%）。COLLEGIUM PHARMACEUTICAL, INCの直近四半期フリーキャッシュフローが多い（$122.4M vs $22.9M）。過去8四半期でCOLLEGIUM PHARMACEUTICAL, INCの売上複合成長率が高い（19.1% vs 18.7%）
コレギウムファーマシューティカルは、乱用抑止機能を持つ革新的な疼痛管理治療薬の開発・販売を専門とする米国の製薬企業です。主に米国市場で慢性疼痛患者向け徐放性鎮痛剤を提供し、一般医療・専門医療現場の医療従事者向けに製品を展開しています。
Ecovyst Inc.は持続可能な特殊材料をグローバルに提供する企業で、高性能触媒と機能性添加剤の開発・製造を行っています。産業製造、消費財、環境保護などの分野の顧客に対し、業務効率化と炭素排出削減を支援するソリューションを提供しています。
COLL vs ECVT — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $205.4M | $199.4M |
| 純利益 | $17.0M | — |
| 粗利率 | 62.5% | 23.4% |
| 営業利益率 | 29.6% | 10.9% |
| 純利益率 | 8.3% | — |
| 売上前年比 | 12.9% | 34.0% |
| 純利益前年比 | 35.3% | — |
| EPS（希薄化後） | $0.48 | $0.06 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $205.4M | $199.4M | ||
| Q3 25 | $209.4M | $204.9M | ||
| Q2 25 | $188.0M | $176.1M | ||
| Q1 25 | $177.8M | $143.1M | ||
| Q4 24 | $181.9M | $148.9M | ||
| Q3 24 | $159.3M | $153.9M | ||
| Q2 24 | $145.3M | $154.0M | ||
| Q1 24 | $144.9M | $141.6M |
| Q4 25 | $17.0M | — | ||
| Q3 25 | $31.5M | $-79.3M | ||
| Q2 25 | $12.0M | $6.0M | ||
| Q1 25 | $2.4M | $-3.6M | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $9.3M | $14.3M | ||
| Q2 24 | $19.6M | $8.3M | ||
| Q1 24 | $27.7M | $1.2M |
| Q4 25 | 62.5% | 23.4% | ||
| Q3 25 | 61.7% | 25.4% | ||
| Q2 25 | 57.7% | 22.8% | ||
| Q1 25 | 54.8% | 13.3% | ||
| Q4 24 | 54.0% | 28.9% | ||
| Q3 24 | 60.8% | 29.3% | ||
| Q2 24 | 62.5% | 27.3% | ||
| Q1 24 | 63.1% | 23.5% |
| Q4 25 | 29.6% | 10.9% | ||
| Q3 25 | 29.7% | 13.8% | ||
| Q2 25 | 18.7% | 9.0% | ||
| Q1 25 | 12.2% | -0.7% | ||
| Q4 24 | 20.9% | 15.1% | ||
| Q3 24 | 21.9% | 17.9% | ||
| Q2 24 | 32.7% | 14.1% | ||
| Q1 24 | 34.1% | 9.5% |
| Q4 25 | 8.3% | — | ||
| Q3 25 | 15.0% | -38.7% | ||
| Q2 25 | 6.4% | 3.4% | ||
| Q1 25 | 1.4% | -2.5% | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 5.9% | 9.3% | ||
| Q2 24 | 13.5% | 5.4% | ||
| Q1 24 | 19.1% | 0.9% |
| Q4 25 | $0.48 | $0.06 | ||
| Q3 25 | $0.84 | $-0.69 | ||
| Q2 25 | $0.34 | $0.05 | ||
| Q1 25 | $0.07 | $-0.03 | ||
| Q4 24 | $0.36 | $-0.26 | ||
| Q3 24 | $0.27 | $0.12 | ||
| Q2 24 | $0.52 | $0.07 | ||
| Q1 24 | $0.71 | $0.01 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $386.7M | $197.2M |
| 総負債低いほど良い | — | $392.6M |
| 株主資本純資産 | $301.7M | $603.4M |
| 総資産 | $1.7B | $1.3B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.65× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $386.7M | $197.2M | ||
| Q3 25 | $285.9M | $82.0M | ||
| Q2 25 | $222.2M | $69.6M | ||
| Q1 25 | $197.8M | $127.5M | ||
| Q4 24 | $162.8M | $131.4M | ||
| Q3 24 | $120.0M | $123.5M | ||
| Q2 24 | $271.6M | $83.3M | ||
| Q1 24 | $318.0M | $103.1M |
| Q4 25 | — | $392.6M | ||
| Q3 25 | — | $854.8M | ||
| Q2 25 | — | $856.6M | ||
| Q1 25 | — | $859.0M | ||
| Q4 24 | — | $860.8M | ||
| Q3 24 | — | $862.7M | ||
| Q2 24 | — | $862.4M | ||
| Q1 24 | — | $866.2M |
| Q4 25 | $301.7M | $603.4M | ||
| Q3 25 | $274.8M | $607.9M | ||
| Q2 25 | $232.2M | $692.4M | ||
| Q1 25 | $234.4M | $698.7M | ||
| Q4 24 | $228.8M | $700.5M | ||
| Q3 24 | $234.3M | $729.4M | ||
| Q2 24 | $216.6M | $717.3M | ||
| Q1 24 | $222.2M | $711.4M |
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | $1.6B | $1.7B | ||
| Q2 25 | $1.6B | $1.8B | ||
| Q1 25 | $1.6B | $1.8B | ||
| Q4 24 | $1.7B | $1.8B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.1B | $1.8B | ||
| Q1 24 | $1.1B | $1.8B |
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 1.23× | ||
| Q4 24 | — | 1.23× | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 1.22× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $123.0M | $41.8M |
| フリーキャッシュフロー営業CF - 設備投資 | $122.4M | $22.9M |
| FCFマージンFCF / 売上 | 59.6% | 11.5% |
| 設備投資強度設備投資 / 売上 | 0.3% | 9.4% |
| キャッシュ転換率営業CF / 純利益 | 7.25× | — |
| 直近12ヶ月FCF直近4四半期 | $327.6M | $69.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $123.0M | $41.8M | ||
| Q3 25 | $78.4M | $55.3M | ||
| Q2 25 | $72.4M | $33.0M | ||
| Q1 25 | $55.4M | $10.3M | ||
| Q4 24 | $84.6M | $43.5M | ||
| Q3 24 | $-9.0M | $59.9M | ||
| Q2 24 | $67.4M | $10.0M | ||
| Q1 24 | $61.9M | $36.5M |
| Q4 25 | $122.4M | $22.9M | ||
| Q3 25 | $78.3M | $53.2M | ||
| Q2 25 | $72.4M | $7.8M | ||
| Q1 25 | $54.6M | $-14.0M | ||
| Q4 24 | $84.1M | $30.9M | ||
| Q3 24 | $-9.2M | $53.6M | ||
| Q2 24 | $67.1M | $-9.3M | ||
| Q1 24 | $61.4M | $19.1M |
| Q4 25 | 59.6% | 11.5% | ||
| Q3 25 | 37.4% | 26.0% | ||
| Q2 25 | 38.5% | 4.4% | ||
| Q1 25 | 30.7% | -9.8% | ||
| Q4 24 | 46.2% | 20.7% | ||
| Q3 24 | -5.8% | 34.9% | ||
| Q2 24 | 46.2% | -6.1% | ||
| Q1 24 | 42.3% | 13.5% |
| Q4 25 | 0.3% | 9.4% | ||
| Q3 25 | 0.1% | 1.0% | ||
| Q2 25 | 0.0% | 14.4% | ||
| Q1 25 | 0.4% | 16.9% | ||
| Q4 24 | 0.3% | 8.5% | ||
| Q3 24 | 0.2% | 4.1% | ||
| Q2 24 | 0.2% | 12.5% | ||
| Q1 24 | 0.4% | 12.3% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | 5.52× | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | 4.21× | ||
| Q2 24 | 3.44× | 1.20× | ||
| Q1 24 | 2.23× | 29.90× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
COLL
セグメントデータなし
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
